CNS has worked with over 65 clients, mainly SMEs and several of the current top 10 Pharma and Biotech companies since 2003. Of this number over 50% are US companies, 30% Australian and 20% Europe/Asia. Furthermore, over 90% of our clients have worked with CNS on more than one study and on occasion throughout their product’s early phase development.
